![Karen M. Kumor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karen M. Kumor
Technik-/Wissenschafts-/F&E-Leiter bei Sapphire Therapeutics, Inc.
Profil
Karen M.
Kumor is currently working as Vice President-Clinical Research at Sapphire Therapeutics, Inc. She has a graduate and doctorate degree from The Johns Hopkins University.
Aktive Positionen von Karen M. Kumor
Unternehmen | Position | Beginn |
---|---|---|
Sapphire Therapeutics, Inc.
![]() Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 12.10.2009 |
Ausbildung von Karen M. Kumor
The Johns Hopkins University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Sapphire Therapeutics, Inc.
![]() Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Health Technology |